These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4094816)

  • 1. Theophylline toxicity in a preterm infant: selected clinical aspects.
    Strauss AA; Modanlou HD; Komatsu G
    Pediatr Pharmacol (New York); 1985; 5(3):209-12. PubMed ID: 4094816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline-induced seizures in accidentally overdosed neonates.
    Gal P; Roop C; Robinson H; Erkan NV
    Pediatrics; 1980 Mar; 65(3):547-9. PubMed ID: 7360543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of theophylline toxicity using oral activated charcoal.
    Davis R; Ellsworth A; Justus RE; Bauer LA
    J Fam Pract; 1985 Jan; 20(1):73-4. PubMed ID: 3965603
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple dose activated charcoal for theophylline poisoning in young infants.
    Shannon M; Amitai Y; Lovejoy FH
    Pediatrics; 1987 Sep; 80(3):368-70. PubMed ID: 3627887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe theophylline toxicity with oral activated charcoal and haemodialysis--a case report.
    Lim TK; Tan CC
    Singapore Med J; 1988 Dec; 29(6):601-3. PubMed ID: 3252471
    [No Abstract]   [Full Text] [Related]  

  • 6. Reassessment of theophylline toxicity. Serum concentrations, clinical course, and treatment.
    Bertino JS; Walker JW
    Arch Intern Med; 1987 Apr; 147(4):757-60. PubMed ID: 3827463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated charcoal for theophylline toxicity in a premature infant on the second day of life.
    Jain R; Tholl DA
    Dev Pharmacol Ther; 1992; 19(2-3):106-10. PubMed ID: 1340431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal.
    Rutten J; van den Berg B; van Gelder T; van Saase J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2868-9. PubMed ID: 16115857
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic, hormonal and nutritional effects of long-term theophylline therapy in preterm infants: a case-control study].
    Colonna F; Pahor T; de Vonderweid U; Radillo L; Tamaro G
    Pediatr Med Chir; 1995; 17(4):345-8. PubMed ID: 7491331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of theophylline clearance by oral activated charcoal.
    Berlinger WG; Spector R; Goldberg MJ; Johnson GF; Quee CK; Berg MJ
    Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline intoxication: clinical features and pharmacokinetics during treatment with charcoal hemoperfusion.
    Shechter P; Berkenstat H; Segal E; Rapoport J
    Isr J Med Sci; 1996 Sep; 32(9):766-70. PubMed ID: 8865834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyponatremia and theophylline in very low birthweight premature infants].
    Sann L; Cottancin G; Bourgeois J; Bory C; Baltassat P; Bethenod M
    Arch Fr Pediatr; 1982; 39(7):419-22. PubMed ID: 7149887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management considerations in treating metabolic abnormalities associated with theophylline overdose.
    D'Angio R; Sabatelli F
    Arch Intern Med; 1987 Oct; 147(10):1837-8. PubMed ID: 3662713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of vomiting associated with acute sustained release theophylline poisoning: implications for management with oral activated charcoal.
    Amitai Y; Lovejoy FH
    J Toxicol Clin Toxicol; 1987; 25(7):539-54. PubMed ID: 2895817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline misadventures: Part I.
    O'Donnell J
    Neonatal Netw; 1994 Mar; 13(2):35-43. PubMed ID: 8139520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of theophylline in neonates.
    Simons FE; Rigatto H; Simons KJ
    Semin Perinatol; 1981 Oct; 5(4):337-45. PubMed ID: 7302609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apnea and theophylline in the premature infant. Clinical and pharmacokinetic study in 32 premature infants].
    Cottancin G; Sann L; Bory B; Bourgeois J; Frederich A; Baltassat P; Bethenod M
    Pediatrie; 1981 Mar; 36(2):91-101. PubMed ID: 7232073
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increase in the clearance of theophylline with activated carbon].
    Mangues MA; Pérez C; Castellano A; Bonal J
    Med Clin (Barc); 1986 Sep; 87(7):306. PubMed ID: 3762259
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.